Orthofix Medical Reports Q2 2025 Results: Net Sales Rise 2%, EPS at $(0.36) with $14.1M Net Loss

Reuters
08/05
Orthofix Medical Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Results: Net Sales Rise 2%, EPS at $(0.36) with $14.1M Net Loss

Orthofix Medical Inc. reported its financial results for the second quarter of 2025, showing net sales of $203.1 million, including sales from M6® artificial cervical and lumbar discs. Excluding the M6® discs, pro forma net sales reached $200.7 million, marking an increase of 2% on a reported basis and 4% on a pro forma constant currency basis compared to the second quarter of 2024. The U.S. Spine Fixation segment experienced net sales growth of 5% and procedure volume growth of 7% compared to the same period last year. The company reported a net loss of $14.1 million, or $0.36 per share, on a reported basis. However, non-GAAP pro forma adjusted EBITDA was $20.6 million for the second quarter of 2025, representing a $4.0 million increase compared to the $16.6 million reported for the second quarter of 2024, reflecting a 24.1% growth over the prior year. Orthofix reaffirmed its full-year 2025 financial guidance and highlighted strategic initiatives, such as accelerating distributor transitions in underpenetrated U.S. territories, which are contributing to the company's ongoing transformation efforts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orthofix Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250805632737) on August 05, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10